Invesco Ltd. Morphic Holding, Inc. Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 22,932 shares of MORF stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,932

Previous 22,968 0.16%

Holding current value

$1.31 Million

Previous $808,000 3.34%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$26.12 - $34.07 $940 - $1,226	-36 Reduced 0.16%	22,932 $781,000
Q1 2024 May 14, 2024	SELL	$26.64 - $40.31 $80,506 - $121,816	-3,022 Reduced 11.63%	22,968 $808,000
Q4 2023 Feb 12, 2024	BUY	$19.95 - $31.0 $112,936 - $175,491	5,661 Added 27.85%	25,990 $750,000
Q3 2023 Nov 13, 2023	SELL	$21.33 - $59.42 $1.65 Million - $4.59 Million	-77,168 Reduced 79.15%	20,329 $465,000
Q2 2023 Aug 11, 2023	BUY	$34.33 - $62.11 $568,882 - $1.03 Million	16,571 Added 20.48%	97,497 $5.59 Million
Q1 2023 May 12, 2023	BUY	$26.01 - $48.69 $1.84 Million - $3.45 Million	70,811 Added 700.06%	80,926 $3.05 Million
Q4 2022 Feb 13, 2023	SELL	$24.14 - $30.37 $23,150 - $29,124	-959 Reduced 8.66%	10,115 $270,000
Q3 2022 Nov 14, 2022	BUY	$22.23 - $33.37 $23,630 - $35,472	1,063 Added 10.62%	11,074 $313,000
Q2 2022 Aug 15, 2022	BUY	$19.74 - $43.01 $9,317 - $20,300	472 Added 4.95%	10,011 $217,000
Q1 2022 May 16, 2022	BUY	$36.25 - $52.02 $8,410 - $12,068	232 Added 2.49%	9,539 $382,000
Q4 2021 Feb 14, 2022	SELL	$43.27 - $65.72 $4.33 Million - $6.58 Million	-100,065 Reduced 91.49%	9,307 $441,000
Q3 2021 Nov 15, 2021	BUY	$53.61 - $67.5 $1.68 Million - $2.11 Million	31,313 Added 40.11%	109,372 $6.2 Million
Q2 2021 Aug 17, 2021	BUY	$45.13 - $64.99 $3.29 Million - $4.74 Million	72,993 Added 1440.84%	78,059 $4.48 Million
Q1 2021 May 17, 2021	SELL	$29.77 - $84.85 $1.14 Million - $3.25 Million	-38,330 Reduced 88.33%	5,066 $321,000
Q4 2020 Feb 16, 2021	BUY	$25.66 - $34.55 $233,967 - $315,026	9,118 Added 26.6%	43,396 $1.46 Million
Q3 2020 Nov 16, 2020	BUY	$22.51 - $30.11 $142,600 - $190,746	6,335 Added 22.67%	34,278 $937,000
Q2 2020 Aug 14, 2020	BUY	$12.65 - $29.57 $353,478 - $826,274	27,943 New	27,943 $756,000

Others Institutions Holding MORF

# of Institutions

140

Shares Held

38.7M

Call Options Held

4.2K

Put Options Held

200K

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account